(lp0
S'Assembly Biosciences Inc. ASMB  Wall Street Journal - Mar 12, 2011 Assembly Biosciences Inc. ASMB . search. View All companies. AT CLOSE 4:00 PM EDT 04/13/17. $23.89 USD; 0.12 0.50%.'
p1
aS'Ventrus Biosciences Becomes Assembly Biosciences as Stockholders Approve ... GlobeNewswire  - Jul 14, 2014 NEW YORK, July 14, 2014  -- Ventrus Biosciences, Inc.  today announced that its stockholders have approved the issuance of common stock in connection with the merger between Ventrus and Assembly Pharmaceuticals&nbsp;...Ventrus Merges with Assembly Pharmaceuticals, Changes Name - Genetic Engineering News'
p2
aS'Assembly Biosciences Announces Senior Management Changes GlobeNewswire  - Feb 17, 2015 NEW YORK, Feb. 17, 2015  -- Assembly Biosciences, Inc.  today announced a number of senior management changes.'
p3
aS'Assembly Biosciences Expands Senior Leadership Team GlobeNewswire  - Jan 11, 2016 INDIANAPOLIS, Jan. 11, 2016  -- Assembly Biosciences, Inc. , a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus  and C. difficile  infections, today&nbsp;...'
p4
aS'Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting GlobeNewswire  - Nov 11, 2016 INDIANAPOLIS, Nov. 11, 2016  -- Assembly Biosciences, Inc. , a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus  infection and novel oral&nbsp;...'
p5
aS'Assembly Biosciences  Looks Good: Stock Up 13.9% Yahoo Finance - Jan 18, 2017 Assembly Biosciences, Inc. ASMB was a big mover last session, as the company saw its shares rise nearly 14% on the day.'
p6
aS"Assembly Biosciences Reaches The Clinic Seeking Alpha - Nov 16, 2016 The company's lead product candidate is a potential curative treatment for hepatitis B virus . Although ABI-H0731 is behind in development compared to some others, those ahead may provide a blueprint for action."
p7
aS'Assembly Biosciences Deal Worth at Least $50M Inside INdiana Business - Jan 11, 2017 An international pharmaceutical company has reached an agreement with Assembly Biosciences Inc.  in Carmel involving several compounds to treat gastrointestinal problems.'
p8
aS'Assembly Biosciences Reports Successful Clinical Study on Gemicel Pharmaceutical Technology Magazine   - Dec 9, 2015 On Dec. 9, 2015, Assembly Biosciences, Inc., a biotechnology company focused on developing treatments for hepatitis B virus and Clostridium difficile infections , reported a successful clinical study validating the utility of the oral Gemicel ...'
p9
aS'Zacks: Assembly Biosciences Inc  Given $16.00 Consensus Target Price by ... Sports Perspectives - Apr 14, 2017 Assembly Biosciences logo Assembly Biosciences Inc  has earned a consensus broker rating score of 1.00  from the one brokers that cover the stock, Zacks Investment Research reports.The Brokerages Expect Assembly Biosciences, Inc.  to Post ($0.67 ... - Petro Global News 24'
p10
a.